Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
8.96
+0.18 (2.05%)
At close: Feb 21, 2025, 4:00 PM
8.76
-0.20 (-2.23%)
After-hours: Feb 21, 2025, 6:37 PM EST
Pulmonx Market Cap
Pulmonx has a market cap or net worth of $353.81 million as of February 21, 2025. Its market cap has decreased by -35.46% in one year.
Market Cap
353.81M
Enterprise Value
308.80M
1-Year Change
-35.46%
Ranking
Category
Stock Price
$8.96
Market Cap Chart
Since the IPO on October 1, 2020, Pulmonx's market cap has decreased from $1.33B to $353.81M, a decrease of -73.47%. That is a compound annual growth rate of -26.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2025 | 346.70M | 29.31% |
| Dec 31, 2024 | 268.12M | -45.11% |
| Dec 29, 2023 | 488.43M | 54.88% |
| Dec 30, 2022 | 315.36M | -73.31% |
| Dec 31, 2021 | 1.18B | -52.01% |
| Dec 31, 2020 | 2.46B | 84.60% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |